Meta-analysis makes case for drug-eluting stents in STEMI TheHeart.Org New York, NY - Newer-generation drug-eluting stents, particularly the everolimus-eluting stent (Xience V, Abbot; Promus, Boston Scientific), significantly reduce the risk of target vessel revascularization (TVR) in patients with ST-segment-elevation MI ... |
